Navigation Links
Solidus Bioscience Protect their Research and Improve Efficiency With Amphora's PatentSafe Solution
Date:4/16/2009

Biotechnology and contract research company Solidus Bioscience Inc have successfully implemented Amphora's PatentSafe solution to replace their bound lab notebooks. Solidus are using PatentSafe as a fully electronic lab notebook, with digital signatures. Not only does this fit more efficiently into today's laboratories but it also allows them to partition and search their data simply and effectively, saving significant time previously spent on laborious manual searches and compilation of reports.

Cheyenne, WY (PRWEB) April 16, 2009 -- Amphora Research Systems is pleased to announce that Solidus Bioscience Inc. has implemented PatentSafe for their e-notebook initiative. Solidus, with Research Labs in both New York and California, currently offers an in vitro toxicity screening service that determines compound and metabolite toxicity using a novel platform that supports arrays of miniaturized 3D cell cultures and metabolizing enzymes. Solidus has opted for Amphora's PatentSafe Starter Pack option, which is targeted specifically at startup companies and small biotechs, to document contract studies and new product development.

With their research team split between the East and West coast, Solidus were keen to implement a solution which would help their scientists to co-ordinate and collaborate effectively. Having access to all the research information and project reports via the secure PatentSafe server is something that has allowed Solidus to work more effectively as a team.

Solidus carries out a mix of contract research and testing for client companies and internal discovery work of their own. Using PatentSafe's simply configured metadata it is now easy for the researchers to quickly access work done for a particular company or for a development project by everyone in the company simultaneously.

Jessica Ryan, a leading research scientist at Solidus said "Being able to put our experiments straight into PatentSafe has made life much easier for the scientists, giving us back the time we used to spend on cutting and sticking into our paper notebooks. Protecting our intellectual property is very important to us, and we feel that PatentSafe helps us document our work more efficiently and completely."

She continued, "The PatentSafe Starter Pack was ideal for us. The small financial outlay meant that we were able to move quickly from deciding the PatentSafe software was a good fit for our business needs, to implementing it and seeing the benefits we were after."

Having the option run the software remotely on a secure hosted server meant that Solidus did not need to worry about setting up and maintaining additional IT infrastructure. Deployment and training was simple and painless.

Allison Coles, CSO and co-founder of Amphora said, "Contract Research Organizations (CROs) have a particular set of problems. Not only do they want to be able to search, share and secure their work, but they need to be able to divide it simply, so each client can have a copy of their own work. Previously CROs would need to run a set of notebooks for each client company. Using PatentSafe it's simple for them to pull together the all the relevant work for each company, at the end of the contract, or whenever you need to. This removes a lot of time consuming admin from the researchers and lets them work in a more efficient way."

The Starter Pack Subscription of PatentSafe is specifically aimed at biotechs with up to 10 scientists. The Starter pack offering brings the Enterprise-class capabilities of PatentSafe to companies who find themselves with Enterprise-scale problems but until now haven't had the infrastructure or financial ability to do anything but struggle on with the Paper Lab Notebook. Now they can have a quick, easy, and cost effective solution that can grow with them and their success.

Notes for Editors

About Amphora Research Systems:
Launched in 1996, Amphora Research Systems is one of the world's leading suppliers of electronic laboratory notebooks. Its software products, including PatentSafe, are used around the world by large and small companies, including those in the pharmaceutical and chemical sectors. PatentSafe helps scientists to work better, collaborate easily with each other, and protect their inventions.

In July 2007, Amphora was awarded Frost & Sullivan's Market Penetration award based on its continued success in the ELN market.

For further information, please contact:
Jo Worthington, Amphora Research Systems
Tel US: +1 800-221-3916×2029
Tel UK: +44 (0) 845 2300160×2029
Email: jow @ amphora-research.com
http://www.amphora-research.com

About Solidus:
Solidus Biosciences, Inc., a Delaware registered company, was founded in August 2002. Solidus' technology supports new product development in the pharmaceutical, biotechnology, cosmetics, and nutraceutical industries by providing a high throughput assay platform that generates metabolic toxicity data to assess the safety of compounds at a speed and scale appropriate early in the development process.
http://www.solidusbiosciences.com
(818) 388-6576

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2326894.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Research Future has a half cooked research report on Global Liquid ... and expected to reach USD 450 Million by the end of ... ... assessed as a swiftly growing market and expected that the market ... There has been a tremendous growth in the prevalence of cancer ...
(Date:1/19/2017)... , Jan 19, 2017 Research and Markets ... has announced the addition of the ... Application - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future ... till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 ... Inc., a privately-held immunotherapeutics company targeting infectious diseases, ... for the merger of PharmAthene and Altimmune in ... Venture Fund, HealthCap, Truffle Capital and Redmont Capital. ... diversified immunotherapeutics company with four clinical stage and ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical Informatics ... its Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data sharing ... existing policy. AMIA recommended that NIH earmark funding for researchers to produce and ...
Breaking Biology Technology:
(Date:12/15/2016)... Canada and BADEN-BADEN, Germany , ... a leading global financial services provider, today announced an agreement ... passive behavioural biometrics, to join forces. The partnership will enable ... mitigation strategies in compliance with local data protection regulation. ... In order ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much ... doors or starting the engine. Continental will demonstrate the ... Las Vegas . Through the combination of ... and Entry) and biometric elements, the international technology company ... vehicle personalization and authentication. "The integration of ...
(Date:12/8/2016)...  Singulex, Inc., the leader in Next Generation Immunodiagnostics ... license and supply agreement with Thermo Fisher Scientific, the ... access to Thermo Scientific BRAHMS PCT (Procalcitonin), a biomarker ... to diagnose systemic bacterial infection and sepsis and in ... in assessing the risk of critically ill patients for ...
Breaking Biology News(10 mins):